Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Revolution Medicines, Inc. (RVMD)

BioNTech SE Sponsored ADR and Revolution Medicines, Inc. are both Biotechnology companies. Revolution Medicines, Inc. is the larger, with a market value of $38.1B against $21.6B — 1.8× the size. Revolution Medicines, Inc. grew revenue faster over the last twelve months: 491.1% against −22.7%. BioNTech SE Sponsored ADR has the higher net margin (−63.8% vs −894.4%) and the lower return on invested capital (−34.3% vs 0.00%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 11 and Revolution Medicines, Inc. on 7.

Valuation

Metric BNTX RVMD Biotechnology median
P/E n/m n/m 10.26
P/S 7.88 184.79 9.18
P/B 1.05 16.09 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.84 172.29 8.98
Earnings yield (7.93%) (5.07%) (34.89%)
Free cash flow yield (2.44%) (3.73%) (24.52%)

Profitability

Metric BNTX RVMD Biotechnology median
Gross margin 74.59% 95.62% 65.16%
Operating margin (78.99%) (805.75%) 0.00%
Net margin (63.77%) (894.40%) 0.00%
Free cash flow margin (19.21%) (688.93%) 0.00%
Return on equity (8.29%) (93.56%) (50.12%)
Return on assets (7.22%) (57.07%) (45.60%)
Return on invested capital (34.28%) 0.00% 0.00%

Growth

Metric BNTX RVMD Biotechnology median
Revenue growth (TTM) (22.73%) 491.12% 6.26%
EPS growth (last fiscal year) (77.33%) (66.20%) 29.88%
Revenue growth, 5-year CAGR 42.58% (10.50%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX RVMD Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 8.55 8.36 4.89
Net debt to EBITDA 14.29 1.47 1.01

Dividend

Metric BNTX RVMD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BNTX RVMD Biotechnology median
Market cap 21.57b 38.08b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack